Effect of Perioperative Sleep Quality on Chronic Post-Surgical Pain
Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · Mar 7, 2025
Trial Information
Current as of April 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Aged 18-80 years.
- • 2. Scheduled for elective video-assisted thoracic surgery (VATS).
- • 3. Scheduled for elective modified radical mastectomy (MRM).
- • 4. Scheduled for elective coronary artery bypass grafting (CABG).
- • 5. American Society of Anesthesiologists (ASA) physical status classification I-III.
- • 6. Willing to sign the informed consent form, participate in the study, and complete all follow-up assessments.
- Exclusion Criteria:
- • 1. History of surgery within the past 3 months.
- • 2. Chronic use of opioids or sedatives (defined as use for 3 months or longer).
- • 3. Expected completion time of surgery after 16:00 on the day of operation.
- • 4. Planned transfer to the intensive care unit (ICU) postoperatively.
- • 5. Anticipated hospital stay \<24 hours.
- • 6. Contraindications to wearable device use (e.g., infection at the wrist site, allergy to the wristband material).
About Peking Union Medical College Hospital
Peking Union Medical College Hospital (PUMCH) is a prestigious medical institution and a leading research facility located in Beijing, China. Affiliated with the Chinese Academy of Medical Sciences, PUMCH is renowned for its commitment to advancing healthcare through innovative clinical research and high-quality patient care. The hospital plays a pivotal role in the development and execution of clinical trials across various medical disciplines, focusing on improving treatment outcomes and enhancing medical knowledge. With a multidisciplinary team of experts and state-of-the-art facilities, PUMCH is dedicated to contributing to global health advancements and fostering collaborations in the medical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported